News

Medecins Sans Frontieres/Doctors Without Borders Scientific Day May 10th

MSF Scientific Day 2013 will be streamed live online from the Royal Society of Medicine, London, UK, from 09.00am – 06.00pm (GMT+1) on 10th May 2013

http://www.msf.org.uk/Scientific_Day.aspx

MSF Scientific Day is a unique opportunity to showcase medical and scientific research carried out in MSF programmes around the world. Presenting and debating the findings from our research is vital to improve the quality of our humanitarian programmes. By streaming the event online, we hope to engage the wider humanitarian and global health community in this discussion.

The agenda for this year’s MSF Scientific Day has now been finalised and presentations in the TB session include:

  • TB treatment in a chronic armed conflict setting: treatment outcomes and experiences in Somalia
    Karin Fischer Liddle, MSF
  • The role of social media and health: examining the views and experiences of multidrug resistant tuberculosis (MDR-TB) patient bloggers and TB programme staff on their interaction with blogging
    Shona Horter, MSF
  • Ocular inflammatory disease and ocular tuberculosis in a cohort of patients co-infected with HIV and multidrug-resistant tuberculosis (MDR-TB) in Mumbai, India
    Petros Isaakidis, MSF
  • Effectiveness of the WHO regimen for treatment of multidrug resistant tuberculosis (MDR-TB)
    Maryline Bonnet, Epicentre

Other highlights of the day include:

  • The keynote speech by international health expert, co-founder of the Gapminder Foundation and TED talks alumnus Hans Rosling on the synergy and conflict between research and advocacy. This will be followed by a panel discussion on the impact of MSF’s research.
  • Treatment in conflict and emergency settings including treating hepatitis E in South Sudan
  • New approaches to preventing malaria in Mali and Chad, cholera vaccination in an outbreak in Guinea, and preventing malnutrition in Niger by cash transfer and food supplementation
  • Challenges for MSF including the introduction of a medical error reporting system and parenteral artesunate for severe malaria

Our online viewers can expect:

  • A live stream of Scientific Day presentations and talks
  • A low-bandwidth stream for those with temperamental internet connection
  • A real-time online discussion with the chance to submit questions to presenters
  • An on-line gallery of posters presented at the event
  • Live Twitter Q&A sessions with selected presenters

Get involved in the debate by following @MSF_UK on Twitter and using the #MSFSci hashtag. MSF Scientific Day news will also be available via our Facebook page

Contacts

Kim West, Scientific Day Digital Communications Officer. scientificday.online@london.msf.org

Becky Roby, Conference Organiser: scientifiday@london.msf.org

More News
17 Sep 2019
Earlier this month, the NIH announced two new Funding Opportunity Annoucnements (FOAs) on the topic of Myeloid-Derived Suppressor Cells (MDSC) as potential therapeutic targets in TB/HIV co-infected patients. The purpose of these FOAs is to invite applications for support of innovative clinical,...
14 Aug 2019
FDA released the following press release on Wednesday, August 14th: The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis (TB) of the lungs. “The threat of...
27 Jun 2019
-- Globe Newswire reported on June 20th -- Spero Therapeutics, Inc. , a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant (MDR) bacterial infections and rare diseases, today...